Join Now

Author Archives: Natalie Themm

New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models

Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses

Posted in BioUtah News | Tagged | Leave a comment

Merit Medical Launches SafeGuard Focus Cool™ Compression Device

Modern design advances patient care by combining hemostasis with innovative cooling capability

Posted in BioUtah News | Tagged | Leave a comment

Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelXTM with Primary Care Physicians

98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney disease stages 1-3b.

Posted in BioUtah News | Tagged | Leave a comment

Soft Cell Labs announces new Urinary Tract Infection Test

Soft Cell Labs announces new Urinary Tract Infection Test

Posted in BioUtah News | Tagged | Leave a comment

ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories

ELITechGroup to provide contract development and manufacturing services for HypoxE® IVD Tests designed for Selectra Pro family of clinical chemistry analyzers

Posted in BioUtah News | Tagged , | Leave a comment

bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

Posted in BioUtah News | Tagged | Leave a comment

3M Announces Plans to Create Long Term Value Through Spin-Off of Health Care Business

New 3M will remain a leading global material science innovator serving diverse end markets, with science and technology, manufacturing, global capabilities, and iconic brands

Posted in BioUtah News | Tagged | Leave a comment

Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality

Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality

Posted in BioUtah News, Policy News | Leave a comment

UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022

UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beginning of year projections.

Posted in BioUtah News | Tagged | Leave a comment

Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-0390, an Investigational Emopamil-binding Protein (EBP) Inhibitor for the Treatment of Brain Cancer

Sumitomo Pharma Oncology recently announced the U.S. FDA granted Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein (EBP) inhibitor for the treatment of brain cancer. 

Posted in BioUtah News | Tagged | Leave a comment

Forbes Magazine Recognizes ARUP Among Nation’s Best Employers for Women

ARUP Laboratories’ ongoing commitment to provide an environment of diversity, inclusion, and belonging for all employees has earned the company recognition as one of Forbes magazine’s Best Employers for Women 2022. The Forbes ranking, first published online on Tuesday, July 26, places ARUP 236th on a list of 300 companies nationwide. Winners were chosen based […]

Posted in BioUtah News | Tagged | Leave a comment

Published UCLA and Spectrum Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers

Spectrum Solutions announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry.

Posted in BioUtah News | Tagged | Leave a comment